FOAMIMGTABLETS 1 tablet contains 0.36 g of enrofloxacin

Pharmacological properties

Enrofloxacin possesses a wide spectrum of antibacterial activity against gram-positive and gram-negative bacteria, including E.coli, Haemophillus spp., Klebsiella spp., Pseudomonas spp., Bordetella spp., Campylobacter spp., Erhysipelothrix spp., Corynebacterium spp., Staphylococcus spp., Streptococcus spp., Actinobacillus spp., Clostridium spp., Bacteroides spp., Fusobacterium spp. and Mycoplasma spp. Mechanism of action of enrofloxacin is based on the inhibition of the activity of gyrase ferment affecting the DNA replication in the core of the bacterial cell. Due to the foam-forming basis the agent is evenly distributed along the mucous membrane of the uterus. The resulting carbon dioxide enhances the resorption of enrofloxacin and causes its penetration in the deeper layers of the endometrium.


ENROFLON® FOAMING TABLETS are used for treatment and prevention of inflammations in the uterus after obstetrics, operative expulsion of afterbirth, abortions, complicated and pathological delivery, acute puerperal endometritis in cows.


For prevention ENROFLON® FOAMING TABLETS are administered once in the dose of one tablet immediately after the expulsion of afterbirth, abortion or obstetrics is case of complicated or pathological delivery. For treatment ENROFLON® FOAMING TABLETS should be administered in the dose of 1 – 2 tablets every 24 hours, 2 or 3 times until the clinical recovery of the animal.

Come back